24.98
Schlusskurs vom Vortag:
$25.20
Offen:
$24.95
24-Stunden-Volumen:
4.96M
Relative Volume:
1.01
Marktkapitalisierung:
$12.41B
Einnahmen:
$4.45B
Nettoeinkommen (Verlust:
$205.00M
KGV:
62.45
EPS:
0.4
Netto-Cashflow:
$372.00M
1W Leistung:
-0.60%
1M Leistung:
+3.39%
6M Leistung:
+43.07%
1J Leistung:
+124.44%
Elanco Animal Health Inc Stock (ELAN) Company Profile
Firmenname
Elanco Animal Health Inc
Sektor
Telefon
877-352-6261
Adresse
450 ELANCO CIRCLE, INDIANAPOLIS
Compare ELAN vs TAK, ZTS, HLN, TEVA, UTHR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
ELAN
Elanco Animal Health Inc
|
24.98 | 12.52B | 4.45B | 205.00M | 372.00M | 0.40 |
|
TAK
Takeda Pharmaceutical Co Adr
|
18.66 | 58.95B | 29.85B | 776.90M | 4.35B | 0.2408 |
|
ZTS
Zoetis Inc
|
128.78 | 53.73B | 9.47B | 2.67B | 2.28B | 6.0218 |
|
HLN
Haleon Plc Adr
|
11.27 | 49.47B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
34.22 | 39.98B | 17.41B | 1.43B | 1.00B | 1.2182 |
|
UTHR
United Therapeutics Corp
|
473.42 | 20.69B | 3.13B | 1.27B | 1.12B | 26.39 |
Elanco Animal Health Inc Stock (ELAN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-22 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2025-12-09 | Eingeleitet | Barclays | Overweight |
| 2025-11-21 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2025-11-19 | Hochstufung | Argus | Hold → Buy |
| 2025-10-07 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2025-07-17 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2025-06-26 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2024-12-09 | Eingeleitet | UBS | Buy |
| 2024-12-02 | Eingeleitet | Leerink Partners | Market Perform |
| 2024-09-19 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2024-01-05 | Hochstufung | Stifel | Hold → Buy |
| 2023-12-19 | Eingeleitet | Jefferies | Buy |
| 2023-12-15 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2023-12-07 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2023-04-20 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2022-08-18 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-08-16 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-07-21 | Herabstufung | Goldman | Buy → Sell |
| 2022-07-12 | Eingeleitet | Piper Sandler | Neutral |
| 2021-11-18 | Eingeleitet | Morgan Stanley | Overweight |
| 2021-10-28 | Herabstufung | Stifel | Buy → Hold |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-06-15 | Hochstufung | Cleveland Research | Underperform → Neutral |
| 2021-05-11 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2021-05-11 | Hochstufung | Gabelli & Co | Hold → Buy |
| 2021-04-15 | Eingeleitet | Stifel | Buy |
| 2021-03-22 | Herabstufung | Gabelli & Co | Buy → Hold |
| 2021-02-26 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2020-12-09 | Herabstufung | Argus | Buy → Hold |
| 2020-11-09 | Herabstufung | Barclays | Overweight → Underweight |
| 2020-08-20 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-08-13 | Fortgesetzt | Credit Suisse | Neutral |
| 2020-08-04 | Fortgesetzt | Goldman | Buy |
| 2020-07-27 | Herabstufung | Cleveland Research | Neutral → Underperform |
| 2020-04-02 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2020-01-10 | Eingeleitet | Raymond James | Mkt Perform |
| 2019-12-19 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-11-07 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2019-09-23 | Eingeleitet | Barclays | Overweight |
| 2019-08-26 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2019-08-15 | Hochstufung | UBS | Sell → Neutral |
| 2019-05-23 | Eingeleitet | Guggenheim | Neutral |
| 2019-03-18 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-03-13 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2019-02-12 | Eingeleitet | William Blair | Mkt Perform |
| 2019-01-23 | Eingeleitet | UBS | Sell |
| 2019-01-15 | Eingeleitet | Argus | Buy |
| 2018-10-15 | Eingeleitet | Morgan Stanley | Equal-Weight |
Alle ansehen
Elanco Animal Health Inc Aktie (ELAN) Neueste Nachrichten
Jupiter Asset Management Ltd. Purchases 1,846,907 Shares of Elanco Animal Health Incorporated $ELAN - MarketBeat
Animal Antibiotics Market Growth Report: Industry Dynamics, - openPR.com
4 Analysts Assess Elanco Animal Health: What You Need To Know - Benzinga
Published on: 2026-02-19 21:49:34 - mfd.ru
JPMorgan Chase & Co. Forecasts Strong Price Appreciation for Elanco Animal Health (NYSE:ELAN) Stock - MarketBeat
JP Morgan Raises Price Target for Elanco Animal Health (ELAN) to $28.00 | ELAN Stock News - GuruFocus
Countdown to Elanco Animal Health (ELAN) Q4 Earnings: Wall Street Forecasts for Key Metrics - Yahoo Finance
Elanco to Participate in Upcoming Investor Conferences - Finviz
Five live Elanco investor talks set through March 17, 2026 - Stock Titan
Cencora to refocus on drug distribution with $3.5 billion divestiture of animal health unit - Reuters
Veterinary Medicine Market Booming with Rapid Growth Through 2033 | Ceva, Zoetis, Elanco - openPR.com
Companion Animal Health Market Set for Explosive Growth to US$ - openPR.com
Animal Performance Enhancers Market Forecast Through - openPR.com
Aug Volume: Will Elanco Animal Health Incorporated stock recover after earningsTrade Entry Summary & Detailed Earnings Play Alerts - baoquankhu1.vn
MSN Money - MSN
Northwestern Mutual Investment Management Company LLC Buys Shares of 110,738 Elanco Animal Health Incorporated $ELAN - MarketBeat
Illinois Municipal Retirement Fund Sells 100,254 Shares of Elanco Animal Health Incorporated $ELAN - MarketBeat
Elanco Animal Health (ELAN) to Release Earnings on Tuesday - MarketBeat
Board Exits at Elanco (ELAN) Raise a Quiet Question About Future Innovation and Oversight Balance - Yahoo Finance
Here’s Why Elanco Animal Health Incorporated (ELAN) Declined in Q4 - MSN
Will Elanco Animal Health Incorporated (5EA) stock benefit from sector leadershipEarnings Performance Report & Weekly Watchlist for Consistent Profits - mfd.ru
Elanco Animal Health (ELAN) Stock Analysis: Evaluating Growth Potential in the Animal Healthcare Sector - DirectorsTalk Interviews
Rhumbline Advisers Grows Position in Elanco Animal Health Incorporated $ELAN - MarketBeat
Can Elanco Animal Health Incorporated ride the EV wavePortfolio Growth Summary & Entry Point Confirmation Alerts - mfd.ru
ELANCO ANIMAL HEALTH INCDAVID HOOVER RETIRES FROM ELANCO BOARD (NOT AS 'CHAIRMAN') - Intellectia AI
Why is Elanco Animal Health Incorporated stock going downJuly 2025 WrapUp & Weekly Stock Breakout Alerts - mfd.ru
How currency fluctuations impact Elanco Animal Health Incorporated stockJuly 2025 PreEarnings & Smart Money Movement Alerts - mfd.ru
DDD Partners LLC Acquires 108,941 Shares of Elanco Animal Health Incorporated $ELAN - MarketBeat
Elanco Animal Health Incorporated (NYSE:ELAN) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Elanco Announces Updates to Board of Directors - Investing News Network
Chewy Settles Antitrust Claims Over Elanco Flea & Tick Meds - Law360
Elanco Animal Health Board Members Not Seeking Reelection - Intellectia AI
Elanco Animal Health says David Hoover retires as a member of Elanco board - marketscreener.com
Elanco Animal Health Board Updates Leadership - Intellectia AI
Founding Elanco chair Dave Hoover to step down after 2026 meeting - Stock Titan
Livestock Gut Health Solutions Market to See Thriving Worldwide | Zoetis • Elanco Animal Health • Merck Animal Health - openPR.com
Why retail investors favor Elanco Animal Health Incorporated stockWeekly Market Report & Consistent Income Trade Recommendations - mfd.ru
PRISM MarketView Launches PetCare Index - GlobeNewswire Inc.
Can Elanco Animal Health Incorporated benefit from deglobalizationCEO Change & Weekly Top Gainers Alerts - mfd.ru
Pet Health Stock Barks Up A Beat; Shares Jump - Investor's Business Daily
State of Michigan Retirement System Invests $2.38 Million in Elanco Animal Health Incorporated $ELAN - MarketBeat
Guidance Update: Will Elanco Animal Health Incorporated announce a stock splitJuly 2025 Selloffs & Stepwise Trade Execution Plans - mfd.ru
Wesbanco Bank Inc. Has $1.79 Million Stake in Elanco Animal Health Incorporated $ELAN - MarketBeat
Skylands Capital LLC Lowers Stock Holdings in Elanco Animal Health Incorporated $ELAN - MarketBeat
What’s Elanco Animal Health Incorporated’s historical return2025 Winners & Losers & Intraday High Probability Alerts - mfd.ru
Animal Antibiotics and Antimicrobials Market to Reach US$ 17.85 - openPR.com
Elanco Animal Health (NYSE:ELAN) Hits New 1-Year HighWhat's Next? - MarketBeat
Animal Vaccine Market to Reach US$ 30.48 Billion by 2033 at 7.1% - openPR.com
Companion Animal Healthcare Market Is Going to Boom | Major - openPR.com
Here's What the Street Thinks About Elanco Animal Health Incorporated (ELAN) - Finviz
Here’s What the Street Thinks About Elanco Animal Health Incorporated (ELAN) - Yahoo Finance
Finanzdaten der Elanco Animal Health Inc-Aktie (ELAN)
Umsatz
Nettogewinn
Free Cashflow
ENV
Elanco Animal Health Inc-Aktie (ELAN) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Modi Rajeev A. | SEE REMARKS |
Dec 11 '25 |
Buy |
21.33 |
4,500 |
95,985 |
123,082 |
| VanHimbergen Robert M | EVP and CFO |
Dec 11 '25 |
Buy |
21.64 |
6,950 |
150,426 |
124,233 |
| Simmons Jeffrey N | PRESIDENT, CEO AND DIRECTOR |
Dec 11 '25 |
Buy |
21.75 |
22,000 |
478,496 |
167,000 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):